112 related articles for article (PubMed ID: 1379656)
1. [Adjuvant chemotherapy (MVP-CAB; methotrexate, vincristine, cisplatinum, cyclophosphamide, adriamycin, and bleomycin) for bladder cancer].
Fujii A; Oka N; Murata Y; Higuchi A; Itoh N; Nakagawa J; Tanaka H; Izumi T; Yamada Y
Nihon Hinyokika Gakkai Zasshi; 1992 May; 83(5):619-26. PubMed ID: 1379656
[TBL] [Abstract][Full Text] [Related]
2. Adjuvant chemotherapy for invasive urothelial cancer: experience with a methotrexate, vincristine, cisplatin, cyclophosphamide, adriamycin and bleomycin (MVP-CAB) regimen: a preliminary report.
Gohji K; Higuchi A; Maruyama S; Minayoshi K; Fujii A; Itoh N; Hasunuma Y; Tanaka H; Izumi T
Jpn J Clin Oncol; 1993 Oct; 23(5):291-8. PubMed ID: 7693990
[TBL] [Abstract][Full Text] [Related]
3. [Adjuvant chemotherapy with MVP-CAB (methotrexate, vincristine, cisplatinum, cyclophosphamide, adriamycin and bleomycin) for epithelial tumors of the upper urinary tract].
Fujii A; Oka N; Murata Y; Higuchi A; Itoh N; Ishikawa J; Tanaka H
Nihon Hinyokika Gakkai Zasshi; 1992 Oct; 83(10):1609-14. PubMed ID: 1279258
[TBL] [Abstract][Full Text] [Related]
4. [Combination chemotherapy with methotrexate, vincristine, cisplatinum, cyclophosphamide, adriamycin, and bleomycin (MVP-CAB) for metastatic urothelial cancer].
Fujii A; Oka N; Miyasaki S; Higuchi A; Itoh N; Okamoto Y; Tanaka H; Hiro-oka K; Shimatani N; Inoue T
Nihon Hinyokika Gakkai Zasshi; 1991 Jun; 82(6):932-9. PubMed ID: 1715415
[TBL] [Abstract][Full Text] [Related]
5. [Combination chemotherapy with methotrexate (MTX), vincristine (VCR), cisplatinum (CDDP), cyclophosphamide (CPM), adriamycin (ADM), and bleomycin (BLM); MVP-CAB in patients with advanced urothelial tract cancer].
Fujii A; Morishita S; Nakamura I; Oka Y; Ohshima H; Nagata H; Iwamoto T; Izumi T; Miyasaki Z; Ito N
Nihon Hinyokika Gakkai Zasshi; 1988 Jun; 79(6):985-93. PubMed ID: 2460657
[No Abstract] [Full Text] [Related]
6. [A study of the use of methotrexate, vincristine, cis-platinum, cyclophosphamide, adriamycin, bleomycin (MVP-CAB) in metastatic transitional cell carcinoma].
Fujii A; Den S; Nakamura I; Ohshima H; Nagata H; Izumi T; Takechi Y; Kawaida T; Kamidono S; Yasuno H
Hinyokika Kiyo; 1987 May; 33(5):697-703. PubMed ID: 2444083
[TBL] [Abstract][Full Text] [Related]
7. [Combination chemotherapy with methotrexate, vincristine, cis-platinum, cyclophosphamide, adriamycin, and bleomycin: MVP-CAB for disseminated urological cancer].
Fujii A; Morishita S; Nakamura I; Oka Y; Ohshima H; Nagata H; Iwamoto T; Itoh N; Nakagawa Y; Miyazaki S
Nihon Gan Chiryo Gakkai Shi; 1990 Jan; 25(1):55-62. PubMed ID: 1691254
[TBL] [Abstract][Full Text] [Related]
8. Long-term follow-up results of a Pilot Phase II study of multidrug chemotherapy (MVP-CAB) in patients with advanced urothelial cancer.
Gohji K; Ono Y; Takenaka A; Nomi M; Okamoto M; Yuen K; Fujii A
Jpn J Clin Oncol; 1999 Apr; 29(4):204-8. PubMed ID: 10340044
[TBL] [Abstract][Full Text] [Related]
9. Phase II study of a new combined primary chemotherapy regimen, intravenous methotrexate and vincristine and intraarterial adriamycin and cisplatin, for locally advanced urinary bladder cancer: preliminary results.
Kuroiwa T; Naito S; Hasuo K; Kishikawa T; Masuda K; Kumazawa J
Cancer Chemother Pharmacol; 1995; 35(5):357-63. PubMed ID: 7850915
[TBL] [Abstract][Full Text] [Related]
10. Prognostic significance of adjuvant cisplatin-based combination chemotherapy following radical cystectomy in patients with invasive bladder cancer.
Muramaki M; Miyake H; Kurahashi T; Takenaka A; Inoue TA; Fujisawa M
Int J Urol; 2008 Apr; 15(4):314-8. PubMed ID: 18380818
[TBL] [Abstract][Full Text] [Related]
11. [Neoadjuvant and adjuvant chemotherapy of bladder cancer].
Kuroda M; Kotake T
Gan To Kagaku Ryoho; 1994 Oct; 21 Suppl 3():362-9. PubMed ID: 7986116
[TBL] [Abstract][Full Text] [Related]
12. [Intraarterial COMPA (cis-diammine-dichloroplatinum (II), vincristine, methotrexate, peplomycin, adriamycin) chemotherapy for bladder cancer].
Tsujino S; Ito T; Aizawa T; Namiki K; Ohno Y; Yamamoto S; Ishibashi K; Miki M; Yamauchi T; Kawai T
Hinyokika Kiyo; 1992 Oct; 38(10):1101-7. PubMed ID: 1282770
[TBL] [Abstract][Full Text] [Related]
13. [Adjuvant chemotherapy following total cystectomy for invasive bladder cancer with bleomycin, vincristine and methotrexate].
Takeuchi S; Yamada T; Sekine H; Katoh M; Washizuka M; Fukui I; Yokokawa M
Hinyokika Kiyo; 1984 Nov; 30(11):1619-25. PubMed ID: 6084949
[TBL] [Abstract][Full Text] [Related]
14. [Sequential combination chemotherapy consisting of vincristine, peplomycin, methotrexate, cis-diamminedichloroplatinum (II), cytosine arabinoside and 5-fluorouracil, for advanced urothelial cancer].
Yamauchi T; Hida S; Ooishi K; Okada K; Yoshida O
Hinyokika Kiyo; 1985 Jul; 31(7):1093-104. PubMed ID: 2414981
[TBL] [Abstract][Full Text] [Related]
15. Adjuvant chemotherapy for deep muscle-invasive transitional cell bladder carcinoma - a practice guideline.
Segal R; Winquist E; Lukka H; Chin JL; Brundage M; Markman BR;
Can J Urol; 2002 Oct; 9(5):1625-33. PubMed ID: 12431323
[TBL] [Abstract][Full Text] [Related]
16. [Results of the first Austrian multicenter ovarian cancer study: prospective randomized comparison of sequential chemotherapy (adriamycin/cisplatin--vincristine/cyclophosphamide--methotrexate) with 2 standard protocols (adriamycin/cyclophosphamide or adriamycin/cisplatin) in stage III and IV patients].
Salzer H; Gitsch E; Dittrich C; Sevelda P; Karrer K; Schemper M; Stempel-Smekal G; Langer M; Wagner G; Rainer H
Geburtshilfe Frauenheilkd; 1985 Nov; 45(11):761-8. PubMed ID: 3908214
[TBL] [Abstract][Full Text] [Related]
17. [Conservative treatment of locally advanced bladder carcinoma: neoadjuvant chemotherapy, TUR and radiotherapy. Results in 40 patients].
Serretta V; Vasile P; Falletta V; Piazza F; Pavone C; Pavone-Macaluso M
Arch Ital Urol Androl; 1998 Jun; 70(3 Suppl):37-40. PubMed ID: 9707769
[TBL] [Abstract][Full Text] [Related]
18. Combination chemotherapy for metastatic urinary bladder cancer with 5-FU, vincristine, bleomycin, cyclophosphamide, mitomycin, and methotrexate.
Kubota Y; Shuin T; Miura T; Moriyama M; Fukushima S; Shiozaki H; Ooshima H
Cancer Treat Rep; 1984 Sep; 68(9):1167-8. PubMed ID: 6206946
[TBL] [Abstract][Full Text] [Related]
19. Combination chemotherapy with intra-arterial cisplatin and doxorubicin plus intravenous methotrexate and vincristine for locally advanced bladder cancer. Kyushu University Urological and Radiological Oncology Group.
Naito S; Kuroiwa T; Ueda T; Hasuo K; Masuda K; Kumazawa J
J Urol; 1995 Nov; 154(5):1704-9. PubMed ID: 7563327
[TBL] [Abstract][Full Text] [Related]
20. [Squamous cell carcinoma of the bladder treated with a new combined chemotherapy regimen, intraarterial nedaplatin and pirarubicin plus intravenous methotrexate and vincristine--second case report in Japan].
Shigehara K; Kitagawa Y; Nakashima T; Shimamura M; Katayanagi K; Kurumaya H
Gan To Kagaku Ryoho; 2007 Aug; 34(8):1319-21. PubMed ID: 17687223
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
